KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hims & Hers Health (HIMS) Non-Current Deffered Revenue (2019 - 2021)

Hims & Hers Health's Non-Current Deffered Revenue history spans 3 years, with the latest figure at $384000.0 for Q1 2021.

  • On a quarterly basis, Non-Current Deffered Revenue fell 94.55% to $384000.0 in Q1 2021 year-over-year; TTM through Mar 2021 was $384000.0, a 94.55% decrease, with the full-year FY2020 number at $381000.0, down 94.59% from a year prior.
  • Non-Current Deffered Revenue hit $384000.0 in Q1 2021 for Hims & Hers Health, up from $381000.0 in the prior quarter.
  • Over the last five years, Non-Current Deffered Revenue for HIMS hit a ceiling of $7.0 million in Q3 2019 and a floor of $381000.0 in Q4 2020.
  • Historically, Non-Current Deffered Revenue has averaged $5.1 million across 3 years, with a median of $7.0 million in 2019.
  • The widest YoY moves for Non-Current Deffered Revenue: up 0.0% in 2020, down 94.59% in 2020.
  • Tracing HIMS's Non-Current Deffered Revenue over 3 years: stood at $7.0 million in 2019, then crashed by 94.59% to $381000.0 in 2020, then increased by 0.79% to $384000.0 in 2021.
  • Business Quant data shows Non-Current Deffered Revenue for HIMS at $384000.0 in Q1 2021, $381000.0 in Q4 2020, and $7.0 million in Q3 2020.